According to @ai_darpa, Neuralink has developed an ultra-precise AI-powered robotic system capable of implanting 64 ultra-thin wires and 1,024 electrodes into the human brain without leaving any scars. This advanced brain-computer interface technology enables paralyzed individuals to control computers directly with their thoughts, demonstrating practical applications for assistive technology and opening new business opportunities in the neurotechnology and healthcare sectors. The system’s accuracy and minimally invasive approach set a new benchmark for brain-machine interfaces, potentially accelerating adoption in medical device markets and digital health solutions (Source: @ai_darpa, Dec 5, 2025).

According to Sawyer Merritt, Neuralink's next-generation surgical robot can insert threads into the brain in just 1.5 seconds, a significant improvement from the previous 17-second process, revolutionizing the efficiency of brain-computer interface (BCI) implantation (Source: Sawyer Merritt on Twitter). The robot is designed to be compatible with 99% of the global human population, greatly expanding its market reach and scalability in medical AI applications. The updated needle can penetrate over 50mm from the brain's surface, allowing access to more brain regions and enabling advanced AI-driven neurological treatments. Furthermore, the needle cartridge is now 95% less expensive to produce, opening up substantial business opportunities in affordable neurotechnology and AI-powered healthcare solutions (Source: Sawyer Merritt on Twitter).

According to @ai_darpa, researchers have introduced "Circulatronics," a breakthrough technique that integrates AI-driven wireless microdevices with living immune cells to enable targeted, non-invasive brain repair. These gadgets, described in Nature Biotechnology (source: nature.com/articles/s41587-025-02809-3), harvest light energy and travel through the bloodstream, using immune cells as carriers. This allows them to autonomously access inflamed brain regions without surgery and wirelessly stimulate neurons with micrometer accuracy, as demonstrated in mice. The innovation signals a major opportunity for AI-powered neuromodulation therapies, particularly for Alzheimer's, multiple sclerosis, stroke, brain tumors, and chronic pain, offering scalable and minimally invasive solutions for neurological diseases.